Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

SHA:603707 Revenue

Nanjing King-Friend Biochemical Pharmaceutical had revenue of 885.22M CNY in the quarter ending March 31, 2025, with 12.13% growth. This brings the company's revenue in the last twelve months to 3.88B, down -3.15% year-over-year. In the year 2023, Nanjing King-Friend Biochemical Pharmaceutical had annual revenue of 3.93B with 5.89% growth.

• Revenue (ttm): 3.88B
• Revenue Growth: -3.15%
• P/S Ratio: 4.68
• Revenue / Employee: 2.62M
• Employees: 1,451
• Market Cap: 17.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.93B	218.67M	5.89%
Dec 31, 2022	3.71B	26.03M	0.71%
Dec 31, 2021	3.69B	771.81M	26.48%
Dec 31, 2020	2.91B	445.21M	18.03%
Dec 31, 2019	2.47B	769.34M	45.25%